{"name":"Isofol Medical AB","slug":"isofol-medical-ab","ticker":"","exchange":"","domain":"","description":"Isofol Medical AB is a biotechnology company focused on the development of innovative treatments for cancer, with a pipeline of seven drugs in various stages of clinical development.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4wJBVV95cUxPREE0QldybTRQX21Wc21EQmxmR3B3T3dCdlo5SHdxWXE5MnlyX1oxTHhSVVpfMHpKd013YjJJWlhycERRUTh2R2s0ZTJ1RGc3a3lHbGx1ZjV6TWJWdTNxYUpKM3MwdmlBV0FGTkpqNkNLeHRmZDFnSGlQanZST3VsTWtkbXltWjBOeWFWZHZ5OGQwV2pWUnIxUDhiQWctYVFmVjRDS3o1T3dyREVBQzBVNDVYQXY1X2VxMUpJUjNRcXZqa2dNWlhKbHZlTlpHR0pkMzFFUXUxWjd0M05PZWpYdTBjQ3Y3UWhiVVpkRkJSejJuTFR2SDh0NVJYZlpza0pueldfRlZTX1FJeTZJUHNhSGRCWW1IQ3Fna2p4dFJGV2JHLTkxMTRtMGJ2d3UyUTlqb3VEejM0RDNQREtGSFU5dzhSenZLN09idklBa29LLWZyTklIOENQOWZYUkpWQkZlV2hz?oc=5","date":"2026-03-31","type":"pipeline","source":"TradingView","summary":"Isofol receives gross proceeds of 18.9 MSEK in connection with the exercise of warrants and guarantee commitments for warrants of series TO1, and resolves on a directed share issue - TradingView","headline":"Isofol receives gross proceeds of 18.9 MSEK in connection with the exercise of warrants and guarantee commitments for wa","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOX0ZMVXV6d1A1UTc5T3BRSVcteU10RHk3aS00cVlTeHNPdjRNaW1USV9leDZLVTlDZFlOSHo4UF9wOWdtR1FnZ3NONFExVDZfWEgzRG9pREJVdWpzN1p2Zk8tejlpVFh4V3ZIZ1hVLWhCUzVXTVFtLVBZdTJKTXFnbWR2b3RFek02Y0l2TVVBMW1mYUNBQUV1UGppd2xmN3REM2ZiUkgzaERiRm5JeS01d19rT1JpRHVXV0pyTWhKNHZ1TGs?oc=5","date":"2026-03-31","type":"pipeline","source":"TipRanks","summary":"Isofol Raises 18.9 MSEK via TO1 Warrant Exercise and Directed Share Issue - TipRanks","headline":"Isofol Raises 18.9 MSEK via TO1 Warrant Exercise and Directed Share Issue","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOYnZlMnNPWEQ1b2I3d1plZnlMQTJVTEVTTE4tLUp3N1lialVqSGp3RTB6T3UwS3FIUnRZQVVVeGZ5TG9BaUtvc2o4dmF2S3ZoUUxIM0k1WWwwakg1NllOLWVlYXZFQWxWNTZIRVV3c0F6UmE5MnVBS2oyUDJ1MHFXcFlSNTVSdnlVRFRqekZPbE1NZXJ6SlRBZ2ZSYTdCbGZ1MVoyN3d4RV9DQjluZUJBX1ZTMDZDaTBHTzJ4azBhWFFfX2Q5SzV0V1ln?oc=5","date":"2026-03-13","type":"pipeline","source":"TipRanks","summary":"Isofol Sets TO1 Warrant Price and Exercise Window, Targets SEK 19 Million Raise - TipRanks","headline":"Isofol Sets TO1 Warrant Price and Exercise Window, Targets SEK 19 Million Raise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPbFpvYUdyaDgwbXY2RE5vaWxNWWlubHBidGI5bU51VGZTYXF5dk8tVXI1U240MDNaeUxrb1pQcjFTLXhlQUZwRUpyTHdscFJGcUJRTnE2RGwtVzBiUkJJZm1HWnVHeU5SLUVrSkdIZXJBMDJnS2ptZm9rendKeWRqcVpHTzB1QmhkaEtGUzNsZkhoZ3pyQ0tMNU8wRDBFRHM0TnJjVnZNRmp0d3pWSEtxUkJXR0dRZmhmNU94Q0MzRXVzZlktNkVqUjhvbw?oc=5","date":"2026-03-11","type":"pipeline","source":"TipRanks","summary":"Isofol Secures Stakeholder Support Covering 42% of Upcoming TO1 Warrant Exercise - TipRanks","headline":"Isofol Secures Stakeholder Support Covering 42% of Upcoming TO1 Warrant Exercise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxQVnhNZXdySzlrMlJCcC1hSVNBNEVqdTdVbU42QS1DXzEteS1FXzUtQkVtSDhwS3NiZTIwV2M3WEZ6WnhObDlsUVlZbnM5Z2NWQnE1bEV1aGc2WTJMYjU4TWd0SmJDampock55WUstVy04NmZIOW9mUS00NVhsZ0JVam83ajRKaXViX3l1RlZrZGdPY2txWkY4cXZWX2R6a3U3bFRfVHRsT0FodjRKRllYaF93S2l4M0pfRFF6WG1uREdXUW1oN0ZMSUpwN3NuX0lJUkk3ZFg2SGZJYzZyRmdPSzg3cGszQXpYUmR5dUM4NFBLMTFs?oc=5","date":"2025-06-04","type":"pipeline","source":"TradingView","summary":"Isofol announces final terms of the rights issue and the potential overallotment issue - TradingView","headline":"Isofol announces final terms of the rights issue and the potential overallotment issue","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOalJtR2w0aVlVUFlGNlo5bEhmT1RxTmRmcm1FV1l0Z0dCQkVrSVN2aWo3dE1ERTBkR00zbzEwWUtGcjFiM2ZTc3NXeHBsbWZEYlU1Qk9QVXpvT21TMy10NlFiWnhXaTh5NXljeVJvalBmMkNBQXpfZzFUWHNJak1FLXlLZHptaGF2M2plZXQ3NjV3cjZLbmVhM3o1Q01CbXRiZFZQTm83Qlcyam93RnBJOFV4ZG9RU3cwZnJZTUhLejdNakZGbFZN?oc=5","date":"2024-10-01","type":"pipeline","source":"PR Newswire","summary":"PLK-1 Inhibitors Market to Register Immense Growth by 2034 | DelveInsight - PR Newswire","headline":"PLK-1 Inhibitors Market to Register Immense Growth by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxOXzBuc0JZbVVfbkRlejRfMGJkSUd2dlRFVjk5VTRJNWNudzJqdWxWU3dKOUlSV19aTW1RSGZMZUtMTXp1VXZiSWtiRkxKS2xJdXNoOEJYXzNNMXZ4U0hQNGlFUE5GLXNZNXhGdUZjUkVHSlBfeTc5SlVzbnVhckh4WHhBV2VfNnN6bGZVYmx5a2RXd3p3OE81a3JzemttT1F1T190eTVkemg1V2p4NEI1cExteHY4ZnR6SE9kNEhPX2lGYTNURFp6eTZ3cG5UMGE4ekNHbHlnMV9icXB4Sk1RYVdIX0pHSy1sem5CLTBMVnN1WDA?oc=5","date":"2024-09-17","type":"trial","source":"PR Newswire","summary":"CEACAM5 Drugs Market Outlook: Rising Cancer Cases and Clinical Trials to Fuel Growth by 2034 | DelveInsight - PR Newswire","headline":"CEACAM5 Drugs Market Outlook: Rising Cancer Cases and Clinical Trials to Fuel Growth by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxORmREbWNJelp6ZXlnLXdmRHoxSTZtMThKUjE2b01fV2NOR05ZdWhJcENIOEtDakZLOTNJS0sxRVpyZDN3eEg4bzgtNzVlTjloeEhOcE82aE84WmMwME5lYXktZXNHSlJseTQteTFGVmRaMFNqbmx1T2hQcFNIMDhHbnhTek9kZWh6NFVWb2RLeUY4RUhwV0VZd3NmLW5rdWZkZUplZUR0UkF1ODVIVW9IM2NuS05qSEFUV0p1bHpjNkN6UVdCSnlqV0lhVGdKYVlmZHJUbW9aclVpLWVEVHFCSFZWSWQzdkQ4NjlKU29FOTVuXzA0d0RrbQ?oc=5","date":"2023-11-21","type":"trial","source":"PR Newswire","summary":"Colorectal Cancer Treatment Drug Market to Show Immense Growth During the Study Period (2019-2032) | DelveInsight - PR Newswire","headline":"Colorectal Cancer Treatment Drug Market to Show Immense Growth During the Study Period (2019-2032) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE1VM3hqSzcwdWtqa05TRF85UWxjMHNXQzVtcWVvWGRraTJEV1hXQ1hJM3pOanhhR0QwVVVFbzZIVkFCYmtIRmpnX2NPOWhwTlRPSWFpNUdqZ0Y1cTdNeFdxVGUxMTFCYi1iUUs2UW1nYkVhbmlMdFVEVXQyNEU?oc=5","date":"2022-09-25","type":"pipeline","source":"Allied Market Research","summary":"Bone Cancer Treatment Market Size, Share & Growth, 2031 - Allied Market Research","headline":"Bone Cancer Treatment Market Size, Share & Growth, 2031","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}